Atezolizumab after Nivolumab-Induced Inflammatory Polyarthritis: Can Anti-PD-L1 Immunotherapy Be Administered after Anti-PD-1-Related Immune Toxicities?

Swami, U; Lenert, P; Furqan, M; Abu Hejleh, T; Clamon, G; Zhang, J

Zhang, J (reprint author), Univ Iowa, Internal Med, 200 Hawkins Dr, Iowa City, IA 52242 USA.

JOURNAL OF THORACIC ONCOLOGY, 2018; 13 (6): E102

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索